middle.news
EBOS Posts Solid 12% Revenue Growth, Eyes 7% EBITDA Rise in FY26
12:06am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
EBOS Posts Solid 12% Revenue Growth, Eyes 7% EBITDA Rise in FY26
12:06am on Saturday 30th of August, 2025 AEST
Key Points
Underlying revenue up 12% to $12.3 billion
Underlying EBITDA rises 7.5% to $585 million, within guidance
Healthcare and Animal Care segments show robust organic growth and strategic acquisitions
Five acquisitions completed, expanding Southeast Asia and ANZ presence
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ebos (ASX:EBO)
OPEN ARTICLE